Browsing: Johnson & Johnson
It’s that time of year again: the annual tax-loss harvest. It’s happening across the brokerage firms right now, and it’s…
CNBC’s Jim Cramer told investors why he thinks it might be a good time to invest in packaged good stocks…
CNBC’s Jim Cramer on Thursday told investors why he thinks the stock of Johnson & Johnson is performing well this…
The market wants a Federal Reserve interest-rate cut soon, but it doesn’t want to need one. Wall Street economists are…
A week removed from a brutal payroll report that triggered worry over a tapped consumer and a trapped Federal Reserve,…
CNBC’s Jim Cramer on Friday told investors what to follow next week as earnings season kicks off, highlighting reports from…
CNBC’s Jim Cramer reviewed why certain stocks that are usually considered safe bets — like pharmaceuticals or consumer packaged goods…
Goldman Sachs named pharmaceutical giant Johnson & Johnson to its “U.S. Conviction List – Directors’ Cut” of the most recommended…